United States Biotechnology & Medical Research

Cassava Sciences Inc (SAVA)

Track

Track

Cassava Sciences Inc. experienced notable insider trading activity throughout late 2025. Executives, primarily CEO Richard Barry, executed multiple significant share purchases between September and November. These acquisitions represent the most recent market movements, concluding on November 24, 2025. No further transactions occurred within the last three months, indicating a period of relative quiet for corporate leadership.
Ticker: SAVA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cassava Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
0.6
Anderson Robert Eugene Jr Non-Executive Director
Transaction date
Purchase
Price
87.27
Quantity 80,670 -31.7%
Value US$4,449,057
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
14.38
Quantity 28,534 -38.0%
Value US$1,799,401
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
496.37
Quantity 75,994 -0.7%
Value US$229,588
1.5
Cook Robert Christopher Chief Operating & Legal Office Officer
Transaction date
Purchase
Price
2.91
Quantity 13,725 +inf%
Value US$39,940
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.28
Quantity 7,172 +1.0%
Value US$16,352
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.29
Quantity 46,908 +7.1%
Value US$107,419
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.25
Quantity 400 +0.1%
Value US$900
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.24
Quantity 185,233 +39.0%
Value US$414,922
3.2
Barry Richard President & CEO Executive Director
Transaction date
Purchase
Price
2.13
Quantity 5,400 +1.2%
Value US$11,502
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.86
Quantity 59,800 -83.9%
Value US$230,828
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Sale
Price
3.82
Quantity 2,000 -100.0%
Value US$7,640
2.3
Kupiec James William Chief Medical Officer Officer
Transaction date
Sale
Price
3.87
Quantity 4,000 -100.0%
Value US$15,480
3.0
Schoen, Eric J. (SAVA) Officer Officer
Transaction date
Proposed sale
Price
3.82
Quantity 2,000
Value US$7,640
3.0
Schoen Eric Officer Officer
Transaction date
Proposed sale
Price
3.86
Quantity 59,800
Value US$230,966
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
17.45
Quantity 30,000 +3.5%
Value US$523,500
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.65
Quantity 16,571 +6.0%
Value US$275,907
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
16.80
Quantity 1,906 +0.7%
Value US$32,021
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
25.76
Quantity 77,276 +39.1%
Value US$1,990,630
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
26.13
Quantity 11,565 +6.2%
Value US$302,193
3.2
Barry Richard Non-Executive Director
Transaction date
Purchase
Price
23.79
Quantity 36,159 +24.1%
Value US$860,223
2.3
Kupiec James William Chief Clinical Dev. Officer Officer
Transaction date
Purchase
Price
24.44
Quantity 2,500 +inf%
Value US$61,100
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
20.69
Quantity 100,000 +10.8%
Value US$2,069,000
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
19.95
Quantity 2,500 +14.5%
Value US$49,875
1.6
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
9.59
Quantity 10,000 +0.9%
Value US$95,900
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
8.92
Quantity 36,281 +4.1%
Value US$323,627
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.04
Quantity 2,000 +7.9%
Value US$14,080
3.9
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
6.98
Quantity 213,719 +32.3%
Value US$1,491,759
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
7.03
Quantity 10,000 +65.4%
Value US$70,300
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
5.53
Quantity 100,000 +10.3%
Value US$553,000
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
4.15
Quantity 10,000 +1.0%
Value US$41,500
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
2.20
Quantity 423,788 +177.4%
Value US$932,334
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.86
Quantity 76,212 +46.9%
Value US$141,754
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.88
Quantity 5,300 +53.0%
Value US$9,964
BARBIER REMI President and CEO Executive Director
Transaction date
Purchase
Price
1.65
Quantity 2,599 +inf%
Value US$4,288
3.0
Schoen Eric Chief Financial Officer Officer
Transaction date
Purchase
Price
1.06
Quantity 10,000 +inf%
Value US$10,600
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.31
Quantity 512,660 -23.7%
Value US$671,738
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 37,817 +30.3%
Value US$39,708
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.05
Quantity 30,992 +33.0%
Value US$32,542
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 21,420 +29.6%
Value US$21,420
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
0.96
Quantity 9,771 +15.6%
Value US$9,380
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.91
Quantity 8,000 -0.4%
Value US$7,254
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.95
Quantity 48,000 -2.2%
Value US$45,682
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
1.02
Quantity 1,200,000 -35.1%
Value US$1,222,200
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.76
Quantity 31,838 +9.4%
Value US$119,711
ROBERTSON SANFORD Non-Executive Director
Transaction date
Purchase
Price
3.69
Quantity 18,162 +5.7%
Value US$67,018
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.44
Quantity 25,000 -8.8%
Value US$111,008
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.75
Quantity 50,000 -1.2%
Value US$237,500
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.50
Quantity 265,000 -5.8%
Value US$1,193,162
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.59
Quantity 7,000 -2.4%
Value US$32,118
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.83
Quantity 67,000 -1.4%
Value US$323,409
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 8,000 -2.7%
Value US$39,122
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.91
Quantity 10,000 -3.2%
Value US$49,060
FRIEDMANN NADAV Chief Operating Officer Executive Director
Transaction date
Sale
Price
4.89
Quantity 25,000 -7.5%
Value US$122,125
Sabretooth Master Fund, L.P. Large shareholder
Transaction date
Sale
Price
4.20
Quantity 44,417 -0.9%
Value US$186,600
BARBIER REMI CEO, Chairman of the Board Executive Director Large shareholder
Transaction date
Purchase
Price
4.22
Quantity 5,000 +0.1%
Value US$21,095
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
6.13
Quantity 15,000 -0.3%
Value US$91,950
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.60
Quantity 16,264 -0.3%
Value US$91,078
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.87
Quantity 11,097 -0.2%
Value US$65,139
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.81
Quantity 6,468 -0.1%
Value US$37,586
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.53
Quantity 9,496 -0.2%
Value US$52,541
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.64
Quantity 6,582 -0.1%
Value US$37,129
BARBIER REMI CEO & Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.75
Quantity 6,457 -0.1%
Value US$37,108
SCHOENHARD GRANT Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.54
Quantity 1,500 -3.0%
Value US$8,310
BARBIER REMI CEO and Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.37
Quantity 7,071 -0.1%
Value US$37,964
BARBIER REMI CEO and Chairman of the Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.42
Quantity 11,065 -0.2%
Value US$59,977
SCHOENHARD GRANT Chief Scientific Officer Officer
Transaction date
Planned sale
Price
5.45
Quantity 1,500 -3.0%
Value US$8,175
BARBIER REMI CEO and Chairman of Board Executive Director Large shareholder
Transaction date
Planned sale
Price
5.53
Quantity 8,238 -0.1%
Value US$45,564
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-24 B Purchase
0.6
Anderson Robert Eugene Jr
Non-Executive Director
80,670 -31.7%
87.27
US$4,449,057 		80,670 -31.7% 87.27 US$4,449,057
2025-11-24 2025-11-20 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
28,534 -38.0%
14.38
US$1,799,401 		28,534 -38.0% 14.38 US$1,799,401
2025-11-20 2025-11-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
75,994 -0.7%
496.37
US$229,588 		75,994 -0.7% 496.37 US$229,588
2025-10-02 2025-09-30 B Purchase
1.5
Cook Robert Christopher

Chief Operating & Legal Office

Officer
13,725 +inf%
2.91
US$39,940 		13,725 +inf% 2.91 US$39,940
2025-09-23 2025-09-22 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
7,172 +1.0%
2.28
US$16,352 		7,172 +1.0% 2.28 US$16,352
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
46,908 +7.1%
2.29
US$107,419 		46,908 +7.1% 2.29 US$107,419
2025-09-22 2025-09-19 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
400 +0.1%
2.25
US$900 		400 +0.1% 2.25 US$900
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
185,233 +39.0%
2.24
US$414,922 		185,233 +39.0% 2.24 US$414,922
2025-09-22 2025-09-18 B Purchase
3.2
Barry Richard

President & CEO

Executive Director
5,400 +1.2%
2.13
US$11,502 		5,400 +1.2% 2.13 US$11,502
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
59,800 -83.9%
3.86
US$230,828 		59,800 -83.9% 3.86 US$230,828
2024-12-03 2024-11-29 S Sale
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 -100.0%
3.82
US$7,640 		2,000 -100.0% 3.82 US$7,640
2024-12-03 2024-11-29 S Sale
2.3
Kupiec James William

Chief Medical Officer

Officer
4,000 -100.0%
3.87
US$15,480 		4,000 -100.0% 3.87 US$15,480
2024-12-02 2024-11-29 PrS Proposed sale
3.0
Schoen, Eric J. (SAVA)

Officer

Officer
2,000
3.82
US$7,640 		2,000 3.82 US$7,640
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Schoen Eric

Officer

Officer
59,800
3.86
US$230,966 		59,800 3.86 US$230,966
2023-08-24 2023-08-23 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
30,000 +3.5%
17.45
US$523,500 		30,000 +3.5% 17.45 US$523,500
2023-08-23 2023-08-22 B Purchase
3.2
Barry Richard
Non-Executive Director
16,571 +6.0%
16.65
US$275,907 		16,571 +6.0% 16.65 US$275,907
2023-08-23 2023-08-21 B Purchase
3.2
Barry Richard
Non-Executive Director
1,906 +0.7%
16.80
US$32,021 		1,906 +0.7% 16.80 US$32,021
2023-03-08 2023-03-07 B Purchase
3.2
Barry Richard
Non-Executive Director
77,276 +39.1%
25.76
US$1,990,630 		77,276 +39.1% 25.76 US$1,990,630
2023-03-08 2023-03-06 B Purchase
3.2
Barry Richard
Non-Executive Director
11,565 +6.2%
26.13
US$302,193 		11,565 +6.2% 26.13 US$302,193
2022-08-25 2022-08-23 B Purchase
3.2
Barry Richard
Non-Executive Director
36,159 +24.1%
23.79
US$860,223 		36,159 +24.1% 23.79 US$860,223
2022-08-24 2022-08-23 B Purchase
2.3
Kupiec James William

Chief Clinical Dev. Officer

Officer
2,500 +inf%
24.44
US$61,100 		2,500 +inf% 24.44 US$61,100
2022-08-16 2022-08-12 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
100,000 +10.8%
20.69
US$2,069,000 		100,000 +10.8% 20.69 US$2,069,000
2022-08-16 2022-08-12 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,500 +14.5%
19.95
US$49,875 		2,500 +14.5% 19.95 US$49,875
2020-09-24 2020-09-24 B Purchase
1.6
BARBIER REMI

President and CEO

Executive Director
10,000 +0.9%
9.59
US$95,900 		10,000 +0.9% 9.59 US$95,900
2020-09-21 2020-09-18 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
36,281 +4.1%
8.92
US$323,627 		36,281 +4.1% 8.92 US$323,627
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
2,000 +7.9%
7.04
US$14,080 		2,000 +7.9% 7.04 US$14,080
2020-09-17 2020-09-17 B Purchase
3.9
ROBERTSON SANFORD
Non-Executive Director
213,719 +32.3%
6.98
US$1,491,759 		213,719 +32.3% 6.98 US$1,491,759
2020-09-17 2020-09-17 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +65.4%
7.03
US$70,300 		10,000 +65.4% 7.03 US$70,300
2019-12-31 2019-12-31 B Purchase BARBIER REMI

President and CEO

Executive Director
100,000 +10.3%
5.53
US$553,000 		100,000 +10.3% 5.53 US$553,000
2019-12-26 2019-12-26 B Purchase BARBIER REMI

President and CEO

Executive Director
10,000 +1.0%
4.15
US$41,500 		10,000 +1.0% 4.15 US$41,500
2019-12-20 2019-12-20 B Purchase ROBERTSON SANFORD Non-Executive Director
423,788 +177.4%
2.20
US$932,334 		423,788 +177.4% 2.20 US$932,334
2019-12-19 2019-12-19 B Purchase ROBERTSON SANFORD Non-Executive Director
76,212 +46.9%
1.86
US$141,754 		76,212 +46.9% 1.86 US$141,754
2019-12-19 2019-12-19 B Purchase Schoen Eric

Chief Financial Officer

Officer
5,300 +53.0%
1.88
US$9,964 		5,300 +53.0% 1.88 US$9,964
2019-12-20 2019-12-18 B Purchase BARBIER REMI

President and CEO

Executive Director
2,599 +inf%
1.65
US$4,288 		2,599 +inf% 1.65 US$4,288
2019-05-15 2019-05-14 B Purchase
3.0
Schoen Eric

Chief Financial Officer

Officer
10,000 +inf%
1.06
US$10,600 		10,000 +inf% 1.06 US$10,600
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-10-05 2018-10-03 S Sale ARMISTICE CAPITAL, LLC Large shareholder
512,660 -23.7%
1.31
US$671,738 		512,660 -23.7% 1.31 US$671,738
2018-09-27 2018-09-27 B Purchase ROBERTSON SANFORD Non-Executive Director
37,817 +30.3%
1.05
US$39,708 		37,817 +30.3% 1.05 US$39,708
2018-09-26 2018-09-26 B Purchase ROBERTSON SANFORD Non-Executive Director
30,992 +33.0%
1.05
US$32,542 		30,992 +33.0% 1.05 US$32,542
2018-09-26 2018-09-25 B Purchase ROBERTSON SANFORD Non-Executive Director
21,420 +29.6%
1.00
US$21,420 		21,420 +29.6% 1.00 US$21,420
2018-09-26 2018-09-24 B Purchase ROBERTSON SANFORD Non-Executive Director
9,771 +15.6%
0.96
US$9,380 		9,771 +15.6% 0.96 US$9,380
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-20 S Sale ARMISTICE CAPITAL, LLC Large shareholder
8,000 -0.4%
0.91
US$7,254 		8,000 -0.4% 0.91 US$7,254
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-17 S Sale ARMISTICE CAPITAL, LLC Large shareholder
48,000 -2.2%
0.95
US$45,682 		48,000 -2.2% 0.95 US$45,682
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2018-08-20 2018-08-16 S Sale ARMISTICE CAPITAL, LLC Large shareholder
1,200,000 -35.1%
1.02
US$1,222,200 		1,200,000 -35.1% 1.02 US$1,222,200
2013-11-07 2013-11-06 B Purchase ROBERTSON SANFORD Non-Executive Director
31,838 +9.4%
3.76
US$119,711 		31,838 +9.4% 3.76 US$119,711
2013-11-07 2013-11-04 B Purchase ROBERTSON SANFORD Non-Executive Director
18,162 +5.7%
3.69
US$67,018 		18,162 +5.7% 3.69 US$67,018
2011-10-24 2011-10-18 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -8.8%
4.44
US$111,008 		25,000 -8.8% 4.44 US$111,008
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
50,000 -1.2%
4.75
US$237,500 		50,000 -1.2% 4.75 US$237,500
2011-10-05 2011-10-04 S Sale Sabretooth Master Fund, L.P. Large shareholder
265,000 -5.8%
4.50
US$1,193,162 		265,000 -5.8% 4.50 US$1,193,162
2011-10-04 2011-10-04 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
7,000 -2.4%
4.59
US$32,118 		7,000 -2.4% 4.59 US$32,118
2011-10-05 2011-10-03 S Sale Sabretooth Master Fund, L.P. Large shareholder
67,000 -1.4%
4.83
US$323,409 		67,000 -1.4% 4.83 US$323,409
2011-10-04 2011-10-03 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
8,000 -2.7%
4.89
US$39,122 		8,000 -2.7% 4.89 US$39,122
2011-10-04 2011-09-30 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
10,000 -3.2%
4.91
US$49,060 		10,000 -3.2% 4.91 US$49,060
2011-09-21 2011-09-15 S Sale FRIEDMANN NADAV

Chief Operating Officer

Executive Director
25,000 -7.5%
4.89
US$122,125 		25,000 -7.5% 4.89 US$122,125
2011-08-10 2011-08-08 S Sale Sabretooth Master Fund, L.P. Large shareholder
44,417 -0.9%
4.20
US$186,600 		44,417 -0.9% 4.20 US$186,600
2011-08-08 2011-08-08 B Purchase BARBIER REMI

CEO, Chairman of the Board

Executive Director Large shareholder
5,000 +0.1%
4.22
US$21,095 		5,000 +0.1% 4.22 US$21,095
2010-10-04 2010-10-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
15,000 -0.3%
6.13
US$91,950 		15,000 -0.3% 6.13 US$91,950
2010-09-08 2010-09-07 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
16,264 -0.3%
5.60
US$91,078 		16,264 -0.3% 5.60 US$91,078
2010-09-02 2010-09-02 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
11,097 -0.2%
5.87
US$65,139 		11,097 -0.2% 5.87 US$65,139
2010-08-10 2010-08-09 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,468 -0.1%
5.81
US$37,586 		6,468 -0.1% 5.81 US$37,586
2010-08-10 2010-08-06 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
9,496 -0.2%
5.53
US$52,541 		9,496 -0.2% 5.53 US$52,541
2010-08-04 2010-08-04 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,582 -0.1%
5.64
US$37,129 		6,582 -0.1% 5.64 US$37,129
2010-08-04 2010-08-03 PlS Planned sale BARBIER REMI

CEO & Chairman of the Board

Executive Director Large shareholder
6,457 -0.1%
5.75
US$37,108 		6,457 -0.1% 5.75 US$37,108
2010-07-20 2010-07-16 PlS Planned sale SCHOENHARD GRANT

Chief Scientific Officer

Officer
1,500 -3.0%
5.54
US$8,310 		1,500 -3.0% 5.54 US$8,310
2010-07-08 2010-07-07 PlS Planned sale BARBIER REMI

CEO and Chairman of the Board

Executive Director Large shareholder
7,071 -0.1%
5.37
US$37,964 		7,071 -0.1% 5.37 US$37,964
2010-07-02 2010-07-02 PlS Planned sale BARBIER REMI

CEO and Chairman of the Board

Executive Director Large shareholder
11,065 -0.2%
5.42
US$59,977 		11,065 -0.2% 5.42 US$59,977
2010-06-17 2010-06-16 PlS Planned sale SCHOENHARD GRANT

Chief Scientific Officer

Officer
1,500 -3.0%
5.45
US$8,175 		1,500 -3.0% 5.45 US$8,175
2010-06-03 2010-06-03 PlS Planned sale BARBIER REMI

CEO and Chairman of Board

Executive Director Large shareholder
8,238 -0.1%
5.53
US$45,564 		8,238 -0.1% 5.53 US$45,564
Explore more

More insider trading research around Cassava Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America